Martingale Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-38,629
| Closed | -$1.48M | – | 864 |
|
|
2023
Q2 | $1.48M | Sell |
38,629
-6,909
| -15% | -$265K | 0.03% | 343 |
|
|
2023
Q1 | $1.05M | Buy |
45,538
+5
| +0% | +$116 | 0.02% | 430 |
|
|
2022
Q4 | $1.19M | Buy |
45,533
+206
| +0.5% | +$5.4K | 0.02% | 407 |
|
|
2022
Q3 | $892K | Buy |
45,327
+4,110
| +10% | +$80.9K | 0.02% | 474 |
|
|
2022
Q2 | $721K | Buy |
41,217
+1,300
| +3% | +$22.7K | 0.01% | 556 |
|
|
2022
Q1 | $654K | Buy |
39,917
+11,902
| +42% | +$195K | 0.01% | 580 |
|
|
2021
Q4 | $457K | Buy |
28,015
+15,200
| +119% | +$248K | 0.01% | 664 |
|
|
2021
Q3 | $164K | Buy |
+12,815
| New | +$164K | ﹤0.01% | 831 |
|